miR-1246 as a therapeutic target in oral submucosa fibrosis pathogenesis

MLA

Chuan-Hang Yu, et al. “MiR-1246 as a Therapeutic Target in Oral Submucosa Fibrosis Pathogenesis.” Journal of the Formosan Medical Association, vol. 118, no. 7, July 2019, pp. 1093–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6391b433f7e76a8abae57c4eef5ac562&authtype=sso&custid=ns315887.

APA

Chuan-Hang Yu, Ming-Yung Chou, Pei-Ling Hsieh, Chia-Ming Liu, Pin Ju Chueh, Po-Yu Yang, Taichen Lin, Yi-Wen Liao, & Cheng-Chia Yu. (2019). miR-1246 as a therapeutic target in oral submucosa fibrosis pathogenesis. Journal of the Formosan Medical Association, 118(7), 1093–1098.

Chicago

Chuan-Hang Yu, Ming-Yung Chou, Pei-Ling Hsieh, Chia-Ming Liu, Pin Ju Chueh, Po-Yu Yang, Taichen Lin, Yi-Wen Liao, and Cheng-Chia Yu. 2019. “MiR-1246 as a Therapeutic Target in Oral Submucosa Fibrosis Pathogenesis.” Journal of the Formosan Medical Association 118 (7): 1093–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6391b433f7e76a8abae57c4eef5ac562&authtype=sso&custid=ns315887.